2nd USENIX Conference on Domain-Specific Languages - Call for Papers

2nd USENIX Conference on Domain-Specific Languages (DSL'99)
October 3-6, 1999
Austin, Texas


Sponsored by USENIX, the Advanced Computing Systems Association
Co-sponsored by ACM SIGPLAN, in cooperation with ACM SIGSOFT (pending)


=================================================
The full Call for Papers can be found at:
http://www.usenix.org/events/dsl99/cfp.html
=================================================


Refereed Papers due: March 22, 1999
Program Chair: Thomas Ball, Lucent Technologies


This conference is dedicated to the discussion of the unique aspects
of domain-specific languages (DSLs): their design, their implementation,
and their use in software engineering. It will include refereed papers,
invited talks, Birds-of-a-Feather (BoF) sessions, and tutorials.


We seek to advance the practice of DSLs generally by:


* eliciting examples of successful DSLs
* highlighting the spectrum of benefits which DSLs can provide
    (e.g., compile-time guarantees of behavior, improve program
    performance, reduced interval, etc.)
* discovering design principles, methodologies for creating DSLs
* eliciting design techniques and tools for working with DSLs
    throughout the software engineering life cycle
* providing a framework within which language designers from
    different domains can easily communicate
* establishing the practical value of DSLs through the publication
    of empirical data concerning productivity, quality, and
    maintainability
* creating a community that will continue to study and refine the
    practice of software engineering through DSLs


======================================================================
USENIX is the Advanced Computing Systems Association. Its members are
the computer technologists responsible for many of the innovations in
computing we enjoy today. To find out more about USENIX, visit its
web site: http://www.usenix.org.
--

Return to the comp.compilers page.
Search the comp.compilers archives again.